Lantus Cancer
Links shared publicly online about this topic
Sanofi rebuffs renewed Lantus cancer worries | Reuters
reuters.com — “LONDON (Reuters) - A Swedish study has rekindled concerns about a possible link between Sanofi's top-selling insulin drug Lantus and cancer, but the French drugmaker said on Wednesday the observational” View full resource at reuters.com
Most Recently Shared on December 7, 2011 at 11:37 am By:
Sanofi rebuffs renewed Lantus cancer worries: LONDON (Reuters) - A Swedish study has rekindled concerns about a ... http://t.co/QMPYBKTe
Study stirs new debate over Lantus-cancer link - FiercePharma
fiercepharma.com — “Once again, the spectre of cancer is haunting Lantus. A new, 1,340-patient study published in Diabetes Care linked higher doses of the Sanofi-Aventis diabetes remedy to a higher cancer risk,... Read more...” View full resource at fiercepharma.com
Most Recently Shared on June 18, 2010 at 2:25 pm By:
Study stirs new debate over Lantus-cancer link. http://bit.ly/cOpZyz
Sanofi Shares Fall on Concern Over Lantus Cancer Risk (Update3) - BusinessWeek
businessweek.com — “Sanofi-Aventis SA fell the most in a month in Paris trading on renewed concern that the Lantus diabetes treatment, the French drugmaker's top-selling product, may be linked to an increased risk of cancer.” View full resource at businessweek.com
Most Recently Shared on June 18, 2010 at 12:13 pm By:
Sanofi Shares Fall on Concern Over #Lantus Cancer Risk (Update3) http://tinyurl.com/2vohskq #diabetes #insulin
Medical News: FDA Still Uncertain About Lantus Cancer Risk - in Endocrinology, Diabetes from MedPage Today
medpagetoday.com — “Eighteen months after starting a probe of potential cancer risks associated with insulin glargine (Lantus), the FDA still hasn't decided whether the concern is justified, the agency said.” View full resource at medpagetoday.com
Most Recently Shared on January 12, 2011 at 10:36 pm By:
FDA Still Uncertain About Lantus Cancer Risk http://bit.ly/exWVO3
Lantus Insulin: Link to Cancer Shaky
diabetes.webmd.com — “Experts say patients should not worry about shaky data suggesting a possible slight cancer risk in people with type 2 diabetes who take lantus, a long-acting insulin.” View full resource at diabetes.webmd.com
Most Recently Shared on July 2, 2009 at 7:37 pm By:
Lantus Insulin: Link to Cancer Shaky: Experts say patients should not worry about shaky data suggesting a possib.. http://tinyurl.com/nvqwm8
Facts About LANTUS®
factsaboutlantus.com — “Clinical studies do not indicate an association of LANTUS® with cancer. LANTUS® has been used safely and effectively by adults and children (6 years and older) in the treatment of type 1 diabetes and in adult patients with type 2 diabetes since it received marketing authorization in 2000.” View full resource at factsaboutlantus.com
Most Recently Shared on July 8, 2009 at 3:30 pm By:
Wendy Blackburn Health Executive
Love it when PR and digital worlds converge. We were able to get this crisis response site up in less than 2 days: http://bit.ly/vIvcI
Sanofi's Lantus avoids meltdown after cancer scare | Reuters
reuters.com — “* Prescriptions for diabetes treatment holding up * Analysts review worst-case forecasts for Lantus sales * Sanofi expected to reiterate confidence at H1 results * Shares up 2.6 percent By” View full resource at reuters.com
Most Recently Shared on July 28, 2009 at 2:19 pm By:
Ben Hirschler Health Communicator
Sanofi's Lantus avoids sales meltdown for now at least. But expect story to come back at EASD meeting in Sept http://tinyurl.com/m8xj9b
FDA Alert: Lantus (insulin glargine)
drugs.com — “FDA Alert: Lantus (insulin glargine)” View full resource at drugs.com
Most Recently Shared on July 2, 2009 at 11:15 pm By:
FDA Alert - FDA Reviewing Safety Data for Lantus (insulin glargine) - http://bit.ly/4pWcvU
Inconclusive research links glargine insulin (Lantus) with cancer - Diabetes UK
diabetes.org.uk — “Diabetes uk’s view on research linking glargine insulin (lantus) with certain cancers.” View full resource at diabetes.org.uk
Most Recently Shared on July 5, 2009 at 8:19 am By:
Inconclusive research links glargine insulin (Lantus) with cancer - http://tinyurl.com/n5gtyk
Is Insulin Glargine (Lantus) Associated with Increased Risk of Cancer? | diabetes
diabeticlive.com — “Is Insulin Glargine (Lantus) Associated with Increased Risk of Cancer: Researchers conducted 11 in vitro studies on human and mice cells to determine whether” View full resource at diabeticlive.com
Most Recently Shared on August 31, 2011 at 1:11 pm By:
Is Insulin Glargine (Lantus) Associated with Increased Risk of Cancer? http://t.co/SS3k69G
Lantus and Cancer: Further Study Needed :: Diabetes Self-Management
diabetesselfmanagement.com — “Late last week, results from several european studies showing a possible link between lantus (insulin glargine) and cancer were published online in the journal diabetologia. health agencies such as the u.s. food and drug administration (fda) and the international diabetes federation (idf) have been swift in their response to the release of this information, indicating that the studies are not conclusive and that people with diabetes should not stop taking lantus without speaking to their doctors” View full resource at diabetesselfmanagement.com
Most Recently Shared on July 1, 2009 at 7:23 pm By:
Diabetes Self-Mgmt Health Site
#diabetes New Blog post by Diane Fennell: Lantus and Cancer: Further Study Needed http://bit.ly/3ZXIL
FDA determines no cancer risk associated with Lantus - MPR
empr.com — “At this time, the FDA has concluded that Lantus (insulin glargine [recombinant], from sanofi-aventis) does not increase the risk of cancer.” View full resource at empr.com
Most Recently Shared on January 25, 2011 at 4:23 pm By:
MPR News: FDA determines no cancer risk associated with Lantus: At this time, the FDA has concluded that Lantus ... http://bit.ly/ftLZYS
FDA determines no cancer risk associated with Lantus - ONA
oncologynurseadvisor.com — “At this time, the FDA has concluded that Lantus (insulin glargine [recombinant], from sanofi-aventis) does not increase the risk of cancer.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 25, 2011 at 3:48 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA determines no cancer risk associated with Lantus http://goo.gl/fb/26fJr
Early Communication About Safety of Lantus (insulin glargine)
fda.gov — “Fda is aware of four recently-published observational studies that looked at the use of lantus (insulin glargine) and possible risk for cancer in patients with diabetes.” View full resource at fda.gov
Most Recently Shared on July 1, 2009 at 7:45 pm By:
FDA Early Communication About Safety of Lantus (insulin glargine) http://bit.ly/10bFXc
Sanofi's Lantus avoids meltdown after cancer scare | Reuters
reuters.com — “* Prescriptions for diabetes treatment holding up * Analysts review worst-case forecasts for Lantus sales * Sanofi expected to reiterate confidence at H1 results * Shares up 2.6 percent By” View full resource at reuters.com
Most Recently Shared on July 28, 2009 at 2:26 pm By:
Ivan Oransky Doctor and Health Communicator
Sales of Lantus, long-acting insulin, hold up, despite studies possibly linking it to cancer RT @reutersBenHir http://is.gd/1R8Yc
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Health News OW
Organizing health news and resources shared by health experts, advocates, and organizations into WisdomCards.
-
FiercePharma
FiercePharma's 140. Join 50,000 pharma insiders on our free newsletter at FiercePharma.com
-
Ellen H Ullman
MSW, Activities Director @DayscapeFL, Dedicated to a cure for type 1 diabetes,VP @cwdfoundation,PEP Squad @diabetes_dri, quintessentially resourceful
Advertisement
